How Much Does CJC-1295 (no DAC), Ipamorelin 10mg (Blend) Cost in 2026? Complete Pricing Breakdown
Key Takeaways
- CJC-1295 (no DAC), Ipamorelin 10mg (Blend) costs $200-$800 monthly through research peptide programs, with consultation fees adding $150-$500 initially
- This peptide blend is research-only and not FDA-approved, limiting availability to specialized research clinics and academic programs[1]
- Insurance does not cover research-only peptides, making all costs out-of-pocket expenses
- HSA/FSA funds cannot be used for research peptides without FDA-approved medical indications
- Monthly program costs vary significantly based on dosing protocols, with 100mcg CJC-1295 + 100mcg Ipamorelin daily costing $300-$600 monthly
- Research participation through clinical trials may provide free access to this peptide combination under IRB-approved protocols
What Is CJC-1295 (no DAC), Ipamorelin 10mg (Blend)?
CJC-1295 (no DAC), Ipamorelin 10mg (Blend) is a research peptide combination that pairs two growth hormone secretagogues with distinct mechanisms of action. CJC-1295 without DAC (Drug Affinity Complex) stimulates growth hormone synthesis through GHRH receptors with a 30-minute half-life, while Ipamorelin activates calcium signaling via the ghrelin receptor with minimal cortisol or prolactin elevation.[2] This blend carries research-only status from the FDA, significantly affecting pricing and availability compared to FDA-approved peptide therapies.
CJC-1295 (no DAC), Ipamorelin 10mg (Blend) Cost Overview
| Cost Category | Low End | High End | Notes |
|---|---|---|---|
| Initial Consultation | $150 | $500 | Research program enrollment |
| Monthly Peptide Supply | $200 | $800 | Varies by dosing protocol |
| Baseline Lab Work | $250 | $600 | IGF-1, comprehensive metabolic panel |
| Monthly Follow-up | $75 | $200 | Telehealth or in-person monitoring |
| Injection Supplies | $25 | $50 | Syringes, alcohol swabs, sharps container |
| Total First Month | $700 | $2,150 | Including all startup costs |
| Ongoing Monthly | $350 | $1,050 | Medication + monitoring + supplies |
Detailed Cost Breakdown
Research Peptide Supply Cost
CJC-1295 (no DAC), Ipamorelin 10mg (Blend) vials typically contain 10mg total peptide content, with ratios varying from 5mg/5mg to 3mg/7mg depending on the research protocol.[3] Monthly supply costs range from $200-$800 based on dosing frequency and vial concentration. Research-grade peptides command premium pricing due to specialized synthesis requirements and limited production volumes compared to FDA-approved medications.
Standard research dosing protocols utilize 100-300mcg of each peptide daily, administered subcutaneously 30 minutes before meals or bedtime.[4] A 10mg blend vial provides approximately 16-50 doses depending on individual peptide concentrations and prescribed amounts. Research clinics typically charge $12-$16 per dose when factoring in peptide cost, reconstitution supplies, and handling fees.
Consultation and Program Fees
Initial consultations for research peptide programs cost $150-$500, with specialized hormone optimization clinics charging premium rates for comprehensive evaluations.[5] These consultations include medical history review, physical examination, discussion of research protocols, and informed consent documentation required for research peptide participation.
Monthly follow-up appointments range from $75-$200, with telehealth options typically 30-40% less expensive than in-person visits. Research programs require more frequent monitoring than FDA-approved therapies, with monthly check-ins standard during the first 3 months of participation. Some clinics offer all-inclusive monthly programs at $450-$900 that bundle consultation, peptide supply, and basic monitoring services.
Required Laboratory Work
Baseline laboratory testing costs $250-$600 and includes IGF-1 levels ($85-$120), comprehensive metabolic panel ($45-$75), lipid panel ($35-$55), and complete blood count ($25-$40).[6] Research protocols often require additional markers like growth hormone stimulation tests ($200-$350) or 24-hour urine growth hormone measurements ($150-$250).
Monitoring labs every 8-12 weeks cost $150-$300, focusing primarily on IGF-1 levels and metabolic markers. Research participants may require more frequent testing than clinical patients, with some protocols mandating monthly IGF-1 measurements during dose optimization phases. Laboratory costs represent 15-25% of total program expenses over the first year.
Insurance Coverage Deep Dive
Insurance plans do not cover research-only peptides like CJC-1295 (no DAC), Ipamorelin 10mg (Blend) since they lack FDA approval for any medical indication.[7] Major insurers including Aetna, Blue Cross Blue Shield, Cigna, and UnitedHealthcare explicitly exclude experimental or investigational treatments from coverage unless part of approved clinical trials.
Medicare and Medicaid similarly exclude research peptides from coverage, with Medicare Part B specifically requiring FDA approval for injectable medications. Private insurance appeals for research peptide coverage have success rates below 5%, even with physician letters of medical necessity.[8] Patients should expect 100% out-of-pocket costs for all aspects of research peptide therapy.
Some insurance plans may cover required laboratory testing if ordered for general health monitoring rather than specifically for peptide therapy monitoring. Providers can sometimes bill IGF-1 testing under diagnostic codes for growth hormone deficiency evaluation (E23.0) rather than experimental treatment monitoring.
HSA/FSA Eligibility
Health Savings Account (HSA) and Flexible Spending Account (FSA) funds cannot be used for research-only peptides without FDA-approved medical indications.[9] IRS Publication 502 specifically excludes experimental treatments unless they are part of approved clinical trials or have received FDA authorization for the patient's specific condition.
Laboratory testing may qualify for HSA/FSA reimbursement if ordered for diagnostic purposes rather than research monitoring. Consultation fees with licensed physicians generally qualify for HSA/FSA payment regardless of the treatment discussed. Patients should maintain detailed records and consult tax professionals before using HSA/FSA funds for any research peptide-related expenses.
Telehealth vs. In-Person Pricing
Telehealth research peptide programs cost $300-$600 monthly for comprehensive services including peptide supply, consultation, and basic monitoring.[10] Popular telehealth platforms specializing in research peptides include specialized hormone clinics that operate in multiple states with licensed physicians overseeing protocols remotely.
In-person research clinics typically charge $500-$900 monthly for similar services, with the premium reflecting overhead costs for physical facilities and in-person examinations. However, in-person programs may offer more comprehensive monitoring including body composition analysis ($50-$100 per session) and detailed physical assessments not available through telehealth platforms.
Telehealth peptide clinics often provide better pricing transparency and standardized protocols compared to individual physician practices. Many telehealth programs include injection training videos, 24/7 support access, and automated peptide refill systems that reduce overall program complexity and hidden costs.
